Skip to main content

GS Global Future Health Care Equity Portfolio

GS Global Future Health Care Equity Portfolio is an equity fund managed by Goldman Sachs in the Sektor – Helse category.

About this fund

GS Global Future Health Care Equity Portfolio is an equity fund run by Goldman Sachs, compared against the Sektor – Helse peer group.

Tracking error against its benchmark is 8.9%.

The fund dates from 2020, giving it 6 years of history.

The manager-stated volatility is 14.9%.

It is measured against MSCI ACWI Health Care Index (Total Return Net) (USD).

Manager
Goldman Sachs
Category
Sektor – Helse
Region
Global
Sector
Health Care
Style
Sector Focus
SFDR
Article 8
ISIN
LU2220395680
Inception
2020-09-30
Benchmark
MSCI ACWI Health Care Index (Total Return Net) (USD)
AUM
91 m USD
Returns
YTD 2.3% · 1Y 0.7% · 3Y 4.6% · 5Y 1.1%
Actively managedEquityGlobalHealth care
YTD Return · NOK
+2,3 %from NAV
The class started 30.09.2020. 10 years does not exist yet; the figure above is since launch, annualised (as of 31.10.2026).
Calculated NOK return from USD · BASE (NOK Calculated)

Computed from NAV history (price return, NOK, to 13 Nov 2026)

Last NAV 11,84 USD · 13 Nov 2026
Returns by period · NOK · net
ann. 3Y+
+2,3 %
YTD
+0,7 %
1y
+4,6 %
3y, annualised
+1,1 %
5y, annualised
Fund size
90,8 mill. USD
Total fund AUM
Management fee
1,50 %
Annual · class Standard
Ongoing charge
1,84 %
Annual · class Standard
Annual cost on platforms
1,38 %
Class Standard · 1 platform · net of platform rebate, incl. platform fee, excl. transaction costs
SFDR
Article 8
Sustainability
Launched
Sept 2020
ISIN LU2220395680
BenchmarkMSCI ACWI Health Care Index (Total Return Net) (USD)
Risk
Volatility (stated by the manager)14,9 %
Beta1,06
Tracking Error8,9 %
About the fund
The fund

GS Global Future Health Care Equity Portfolio is an actively managed global equity fund with history going back to 2020. Its management company is Goldman Sachs Asset Management, the asset management division of the Goldman Sachs group, established in 1988 and headquartered in New York.

Investment philosophy

The mandate is thematic. The fund holds shares in companies that the investment adviser believes can benefit from evolving trends in the healthcare sector, including genomics, precision medicine, life extension and robotic surgery. The objective is capital growth over the longer term.

The managers

Company selection is carried out by the fund's investment adviser.

The portfolio

The portfolio is concentrated, with fewer holdings than comparable funds. North America is the largest region. The steady top holdings include large pharmaceutical companies such as Eli Lilly and AstraZeneca, alongside specialised companies such as Guardant Health and Argenx.

FundTelligence description · 18/10/2026

Portfolio managers

Managed by a team: Goldman Sachs Asset Management International (GSAMI), Investment Adviser; GSAM L.P. and other affiliates may act as Sub-Advisers
The manager names no individual · Source

Position in the peer group

Sector Health Care Equities · 31 funds in the peer group. The number ranked and the date are stated per period. 12 of them converted to NOK.

11 of 22 funds ranked on a calculated return

#20/ 221 year
+0.71% NOK

as of 13 Nov 2026 · Converted from USD to NOK

About the figures

9 of 31 funds in the group hold no figure for the date and are not counted. 1 funds with older figures: up to 5 business days.

#18/ 223 years (ann.)
+4.63% NOK

as of 13 Nov 2026 · Converted from USD to NOK

About the figures

9 of 31 funds in the group hold no figure for the date and are not counted. 1 funds with older figures: up to 5 business days.

#21/ 225 years (ann.)
+1.12% NOK

as of 13 Nov 2026 · Converted from USD to NOK

About the figures

9 of 31 funds in the group hold no figure for the date and are not counted. 1 funds with older figures: up to 5 business days.

Comparison basis

1 year

Comparison basis: Ranked among 22 of 31 funds · 9 left out (4 missing return, 2 return as of an earlier date, 3 return without a stated date) · returns as of 12 Nov 2026–13 Nov 2026

3 years (ann.)

Comparison basis: Ranked among 22 of 31 funds · 9 left out (4 missing return, 2 return as of an earlier date, 3 return without a stated date) · returns as of 12 Nov 2026–13 Nov 2026

5 years (ann.)

Comparison basis: Ranked among 22 of 31 funds · 9 left out (4 missing return, 2 return as of an earlier date, 3 return without a stated date) · returns as of 12 Nov 2026–13 Nov 2026

The positions describe historical return and are not an assessment of the fund, nor investment advice. Past performance is no guarantee of future returns. A position applies only within its own peer group and cannot be compared with positions in other peer groups.

Fund data is taken from the managers’ own reports, otherwise computed from NAV history and, as a last resort, taken from distributor listings. Not official figures; verify with the fund provider before investing.

About our data